Increasing short-term cardiomyocyte progenitor cell (CMPC) survival by necrostatin-1 did not further preserve cardiac function

Cardiovascular Research

Volumn 99, Issue 1, 2013, Pages 83-91

  Feyen, Dries ^a   Gaetani, Roberto ^a,b   Liu, Jia ^a,c   Noort, Willy ^a   Martens, Anton ^a   Den Ouden, Krista ^a   Doevendans, Pieter A ^a,d   Sluijter, Joost P G ^a,d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^d ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

BLI; Cardiac cell therapy; Cardiac progenitor cells; Cell survival; Necrostatin

Indexed keywords

NECROSTATIN 1; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOCYTE PROGENITOR CELL; CELL COUNT; CELL DEATH; CELL SURVIVAL; CELL TYPE; CONTROLLED STUDY; FETUS; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME;

BLI; CARDIAC CELL THERAPY; CARDIAC PROGENITOR CELLS; CELL SURVIVAL; NECROSTATIN;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GREEN FLUORESCENT PROTEINS; HUMANS; IMIDAZOLES; INDOLES; MALE; MICE; MICE, INBRED NOD; MICE, SCID; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION; STEM CELLS; STROKE VOLUME; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSFECTION; VENTRICULAR FUNCTION, LEFT;

EID: 84879392140     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt078     Document Type: Article

References (43)

1. Ptaszek LM, Mansour M, Ruskin JN, Chien KR. Towards regenerative therapy for cardiac disease. Lancet 2012;379:933-942
2. Laflamme MA, Murry CE. Heart regeneration. Nature 2011;473:326-335
3. Smits AM, van Laake LW, den OK, Schreurs C, Szuhai K, van Echteld CJ et al. Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc Res 2009;83:527-535
4. van der Bogt KE, Schrepfer S, Yu J, Sheikh AY, Hoyt G, Govaert JA et al. Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart. Transplantation 2009;87:642-652
5. Terrovitis JV, Smith RR, Marban E. Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res 2010;106:479-494
6. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S et al. Evidence for cardiomyocyte renewal in humans. Science 2009;324:98-102
7. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001;344: 1750-1757 (Pubitemid 32497029)
8. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 2003;100:12313-12318 (Pubitemid 37271557)
9. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114: 763-776 (Pubitemid 37186770)
10. Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, Woodard S et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005;433: 647-653 (Pubitemid 40282999)
11. Pfister O, Mouquet F, Jain M, Summer R, Helmes M, Fine A et al. CD31- but not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 2005;97:52-61 (Pubitemid 40982322)
12. Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004; 95:911-921 (Pubitemid 39435006)
13. van Laake LW, Hassink R, Doevendans PA, Mummery C. Heart repair and stem cells. J Physiol 2006;577:467-478 (Pubitemid 44804006)
14. van Vliet P, Sluijter JP, Doevendans PA, Goumans MJ. Isolation and expansion of resident cardiac progenitor cells. Expert Rev Cardiovasc Ther 2007;5:33-43 (Pubitemid 46157739)
15. Goumans MJ, de Boer TP, Smits AM, van Laake LW, van VP, Metz CH et al. TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res 2007;1:138-149
16. Zhang M, Methot D, Poppa V, Fujio Y,Walsh K, Murry CE. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 2001;33: 907-921 (Pubitemid 32545326)
17. Liu J, Mil AV, Vrijsen K, Zhao J, Gao L, Goumans MJet al. MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1. J Cell Mol Med 2011;15:1474-1482
18. Galluzzi L, Kroemer G. Necroptosis: a specialized pathway of programmed necrosis. Cell 2008;135:1161-1163
19. Oerlemans MI, Koudstaal S, Chamuleau SA, de Kleijn DP, Doevendans PA, Sluijter JP. Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection. Int J Cardiol 2012. Published online ahead of print.
20. Smits AM, van VP, Metz CH, Korfage T, Sluijter JP, Doevendans PA et al. Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology. Nat Protoc 2009;4:232-243
21. Carlotti F, Bazuine M, Kekarainen T, Seppen J, Pognonec P, Maassen JA et al. Lentiviral vectors efficiently transduce quiescent mature 3T3-L1 adipocytes. Mol Ther 2004;9: 209-217 (Pubitemid 38256547)
22. Van Laake LW, Passier R, Monshouwer-Kloots J, Nederhoff MG, Ward-van OD, Field LJ et al. Monitoring of cell therapy and assessment of cardiac function using magnetic resonance imaging in a mouse model of myocardial infarction. Nat Protoc 2007;2: 2551-2567
23. Sluijter JP, van MA, van VP, Metz CH, Liu J, Doevendans PA et al. MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler Thromb Vasc Biol 2010;30:859-868
24. van MA, Grundmann S, Goumans MJ, Lei Z, Oerlemans MI, Jaksani S et al. MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release. Cardiovasc Res 2012;93:655-665
25. Noort WA, Oerlemans MI, Rozemuller H, Feyen D, Jaksani S, Stecher D et al. Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation. J Cell Mol Med 2012;16:1827-1839
26. van Laake LW, Passier R, Doevendans PA, Mummery CL. Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ Res 2008;102:1008-1010 (Pubitemid 351667854)
27. van Laake LW, Passier R, Monshouwer-Kloots J, verkleij AJ, Lips DJ, Freund C et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res 2007;1:9-24 (Pubitemid 350251944)
28. Post S, Smits AM, van den Broek AJ, Sluijter JP, Hoefer IE, Janssen BJ et al. Impaired recruitment of HHT-1 mononuclear cells to the ischemic heart is due to an altered CXCR4/CD26 balance. Cardiovasc Res 2010;85:494-502
29. Hou D, Youssef EA, Brinton TJ, Zhang P, Rogers P, Price ET et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 2005;112:I150-I156 (Pubitemid 41266667)
30. Terrovitis J, Lautamaki R, Bonios M, Fox J, Engles JM, Yu J et al. Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J Am Coll Cardiol 2009; 54:1619-1626
31. van der Spoel TI, Vrijsen KR, Koudstaal S, Sluijter JP, Nijsen JF, de Jongd HW et al. Transendocardial cell injection is not superior to intracoronary infusion in a porcine model of ischemic cardiomyopathy: a study on delivery efficiency. J Cell Mol Med 2012;16:2768-2776
32. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141-148 (Pubitemid 38891685)
33. Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, Schmitt J et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrastenhanced magnetic resonance imaging. Circulation 2003;108:2212-2218 (Pubitemid 37368893)
34. Quyyumi AA, Waller EK, Murrow J, Esteves F, Galt J, Oshinski J et al. CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. Am Heart J 2011;161:98-105
35. Meluzin J, Mayer J, Groch L, Janousek S, Hornacek I, Hlinomaz O et al. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. Am Heart J 2006;152:975.e9-975.e15
36. Losordo DW, Schatz RA, White CJ, Udelson JE, Veereshwarayya V, Durgin M et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 2007;115: 3165-3172 (Pubitemid 47018140)
37. Niagara MI, Haider HK, Jiang S, Ashraf M. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res 2007;100:545-555 (Pubitemid 46673264)
38. Afzal MR, Haider HK, Idris NM, Jiang S, Ahmed RP, Ashraf M. Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kappaB signaling. Antioxid Redox Signal 2010;12:693-702
39. Kutschka I, Kofidis T, Chen IY, von DG, Zwierzchoniewska M, Hoyt G et al. Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts. Circulation 2006;114:I174-I180 (Pubitemid 44297147)
40. Li W, Ma N, Ong LL, Nesselmann C, Klopsch C, Ladilov Y et al. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 2007;25: 2118-2127 (Pubitemid 47258191)
41. Hu S, Huang M, Nguyen PK, Gong Y, Li Z, Jia F et al. Novel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation. Circulation 2011;124:S27-S34
42. Liu J, Narsinh KH, Lan F, Wang L, Nguyen PK, Hu S et al. Early stem cell engraftment predicts late cardiac functional recovery: pre-clinical insights from molecular imaging. Circ Cardiovasc Imaging 2012;5:481-490
43. Gaetani R, Rizzitelli G, Chimenti I, Barile L, Forte E, Ionta V et al. Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application. J Cell Mol Med 2010;14:1071-1077.